Fan HL, Hsieh CB, Kuo SM, Chen TW. Liver transplantation with simultaneous splenectomy increases risk of cancer development and mortality in hepatocellular carcinoma patients. World J Gastrointest Surg 2022; 14(9): 930-939 [PMID: 36185566 DOI: 10.4240/wjgs.v14.i9.930]
Corresponding Author of This Article
Teng-Wei Chen, MD, Associate Professor, Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec 2, Chen-Kung Road, Neihu 114, Taipei 11409, Taiwan. tengweichen@yahoo.com.tw
Research Domain of This Article
Transplantation
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Hsiu-Lung Fan, Chung-Bao Hsieh, Teng-Wei Chen, Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11409, Taiwan
Shih-Ming Kuo, Division of Pediatric Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11409, Taiwan
Author contributions: Fan HL participated in data analysis and the writing of the paper; Hsieh CB participated in research design; Kuo SM participated in research design; Chen TW participated in data interpretation and revision of the paper
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Tri-Service General Hospital, No. 2-108-05-127.
Informed consent statement: Informed consent was not required by the guidance of the institutional review board because this study was a retrospective study and the analysis used clinical data anonymously.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Teng-Wei Chen, MD, Associate Professor, Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec 2, Chen-Kung Road, Neihu 114, Taipei 11409, Taiwan. tengweichen@yahoo.com.tw
Received: April 13, 2022 Peer-review started: April 13, 2022 First decision: May 9, 2022 Revised: May 24, 2022 Accepted: August 24, 2022 Article in press: August 24, 2022 Published online: September 27, 2022 Processing time: 161 Days and 23.3 Hours
ARTICLE HIGHLIGHTS
Research background
Patients undergoing splenectomy were more likely to develop cancer than patients not undergoing splenectomy. There are a number of indications for simultaneous splenectomy in liver transplantation (LT) recipients.
Research motivation
The hypothesis is that simultaneous splenectomy has bad outcomes on cancer and mortality in LT recipients.
Research objectives
The purpose of this study was to compare the outcomes of hepatocellular carcinoma (HCC) recurrence and de novo malignancy development between HCC patients who underwent LT with and without simultaneous splenectomy.
Research methods
Of 120 patients with HCC who received LT with (n = 35) and without (n = 85) simultaneous splenectomy were analyzed by Cox regression analysis, Kaplan–Meier survival curves and log-rank tests.
Research results
Splenectomy and age were both positive independent factors for prediction of cancer development. Splenectomy and hypertension were positive independent factors for prediction of mortality. The splenectomy group had a significantly worse cancer-free survival and overall survival curve compared to the nonsplenectomy group.
Research conclusions
Simultaneous splenectomy should be avoided in patients with HCC undergoing LT.
Research perspectives
Splenic artery ligation is often considered, instead of splenectomy, for achieving the goal of modulation of portal inflow. The direction of the future research is the comparison on cancer outcome between splenectomy and splenic artery ligation.
